Pfizer (PFE) Dividends payables (2009 - 2025)

Pfizer has disclosed Dividends payables across 17 years of filings, most recently posting $2.4 billion for Q4 2025.

• In Q4 2025, Dividends payables changed 0.33% year-over-year to $2.4 billion; the TTM figure through Dec 2025 stood at $2.4 billion (changed 0.33% YoY), while the FY2025 annual figure was $2.4 billion, changed 0.33% from the prior year.
• Dividends payables held at $2.4 billion in Q4 2025, from $2.4 billion in the prior quarter.
• Over the last five years, Dividends payables for PFE reached as high as $2.4 billion in Q2 2025 and fell as low as $2.2 billion in Q3 2021.
• The 5-year median for Dividends payables is $2.3 billion (2022), against an average of $2.3 billion.
• Annual changes were most pronounced in 2021 — Dividends payables advanced 4.02% — and 2025, when it increased 0.33%.
• A 5-year view of Dividends payables shows it stood at $2.2 billion in 2021, then climbed by 2.4% to $2.3 billion in 2022, then increased by 3.0% to $2.4 billion in 2023, then advanced by 2.74% to $2.4 billion in 2024, then rose by 0.33% to $2.4 billion in 2025.
• According to Business Quant data, Dividends payables over the past three periods registered $2.4 billion, $2.4 billion, and $2.4 billion for Q4 2025, Q2 2025, and Q4 2024 respectively.